Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;22(5):1217.
doi: 10.3892/etm.2021.10651. Epub 2021 Aug 26.

Ovarian cancer health politics in Romania and Germany: A comparative study

Ionut Marcel Cobec  1 , Ioan Sas  2 , Aurica Elisabeta Moatar  3   4 , Lavinia Moleriu  5 , Andreas Rempen  1
Affiliations

Ovarian cancer health politics in Romania and Germany: A comparative study

Ionut Marcel Cobec et al. Exp Ther Med. 2021 Nov.

Abstract

Ovarian cancer is known to have a poor prognosis, being the 7th most common cancer type in women with regard to incidence and mortality worldwide. The present study underlines the importance of early diagnosis and prevention management of ovarian cancer. This study is a hospital-based case-control study that was conducted at the same time in two similar hospitals from different countries, Romania and Germany, over three years. The results showed that significant differences were identified for the two groups with regards to the age factor (P<0.001). A risk analysis was performed to determine whether the patients from Romania were exposed to a risk factor. The risk of developing deadly diseases was deemed much higher owing to insufficient protocols or informative programs in Romania. The medical information, early diagnosis and standardized therapy with optimum treatment based on health policy and health care systems, play a key role concerning the management and prognosis of ovarian cancer which are different from country to country.

Keywords: Germany; Romania; early diagnosis; gynecological cancer; ovarian cancer; standardized therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Chen T, Jansen L, Gondos A, Emrich K, Holleczek B, Luttmann S, Waldmann A, Brenner H. Survival of cervical cancer patients in Germany in the early 21st century: A period analysis by age, histology, and stage. Acta Oncol. 2012;51:915–921. doi: 10.3109/0284186X.2012.708105. Gekid cancer survival working group. - DOI - PubMed
    1. McLemore MR, Miaskowski C, Aouizerat BE, Chen LM, Dodd MJ. Epidemiological and genetic factors associated with ovarian cancer. Cancer Nurs. 2009;32:281–288. doi: 10.1097/NCC.0b013e31819d30d6. - DOI - PMC - PubMed
    1. Yoneda A, Lendorf ME, Couchman JR, Multhaupt HA. Breast and ovarian cancers: A survey and possible roles for the cell surface heparan sulfate proteoglycans. J Histochem Cytochem. 2012;60:9–21. doi: 10.1369/0022155411428469. - DOI - PMC - PubMed
    1. Moghaddam SM, Amini A, Morris DL, Pourgholami MH. Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer. Cancer Metastasis Rev. 2012;31:143–162. doi: 10.1007/s10555-011-9337-5. - DOI - PMC - PubMed
    1. Saad AF, Hu W, Sood AK. Microenvironment and pathogenesis of epitelial ovarian cancer. Horm Cancer. 2010;1:277–290. doi: 10.1007/s12672-010-0054-2. - DOI - PMC - PubMed